Visualization of uveal amelanotic melanoma with technetium-99m(V) dimercaptosuccinic acid

P O Kiratli; H Kiratli; M T Ercan; L Kostakoğlu

doi:10.1007/BF03164824

Visualization of uveal amelanotic melanoma with technetium-99m(V) dimercaptosuccinic acid

Ann Nucl Med. 1997 May;11(2):147-9. doi: 10.1007/BF03164824.

Authors

P O Kiratli¹, H Kiratli, M T Ercan, L Kostakoğlu

Affiliation

¹ Department of Nuclear Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey.

PMID: 9212896
DOI: 10.1007/BF03164824

Abstract

The possibility of using technetium-99m(V) dimercaptosuccinic acid, Tc-99m DMSA, in the evaluation of uveal amelanotic melanoma was assessed in this study. Both planar and SPECT images clearly demonstrated the tumor. Following confirmation of our results by contemporaneous ultrasonography and MRI the patient was treated with Iodine-125 brachytherapy. In combination with other diagnostic tests, Tc-99m(V) DMSA scintigraphy may play a role in the detection of uveal melanoma and its possible systemic metastases.

Publication types

Case Reports

MeSH terms

Adult
Brachytherapy
Humans
Iodine Radioisotopes / therapeutic use
Magnetic Resonance Imaging
Male
Melanoma, Amelanotic / diagnosis
Melanoma, Amelanotic / diagnostic imaging*
Melanoma, Amelanotic / radiotherapy
Organotechnetium Compounds*
Succimer*
Technetium Tc 99m Dimercaptosuccinic Acid
Tomography, Emission-Computed, Single-Photon
Uveal Neoplasms / diagnosis
Uveal Neoplasms / diagnostic imaging*
Uveal Neoplasms / radiotherapy

Substances

Iodine Radioisotopes
Organotechnetium Compounds
Technetium Tc 99m Dimercaptosuccinic Acid
Succimer